Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China
· Delayed Price · Currency is CNY 36.26
-0.01 (-0.03%)
Apr 29, 2026, 3:00 PM CST
SHA:603590 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 357.36 | 332.57 | 189.98 | 230.2 | 345.25 | 599.08 | Upgrade
|
| Short-Term Investments | - | - | 53.82 | 183.82 | 0.75 | 10.81 | Upgrade
|
| Trading Asset Securities | 430.11 | 500.43 | 450.66 | 396.41 | 280.37 | 9.04 | Upgrade
|
| Cash & Short-Term Investments | 787.47 | 833 | 694.46 | 810.43 | 626.36 | 618.93 | Upgrade
|
| Cash Growth | 30.60% | 19.95% | -14.31% | 29.39% | 1.20% | -59.49% | Upgrade
|
| Accounts Receivable | 275.14 | 278.09 | 257.38 | 282.83 | 296.39 | 244.38 | Upgrade
|
| Other Receivables | 76.03 | 76.07 | 33.84 | 35.56 | 27.73 | 6.31 | Upgrade
|
| Receivables | 351.17 | 354.16 | 291.22 | 318.39 | 324.13 | 250.69 | Upgrade
|
| Inventory | 58.96 | 54.47 | 72.38 | 48.47 | 36.99 | 47.02 | Upgrade
|
| Other Current Assets | 125.05 | 153.9 | 28.48 | 52.67 | 29.23 | 31.19 | Upgrade
|
| Total Current Assets | 1,323 | 1,396 | 1,087 | 1,230 | 1,017 | 947.83 | Upgrade
|
| Property, Plant & Equipment | 397.8 | 404.15 | 426.73 | 414.54 | 440.14 | 407.06 | Upgrade
|
| Long-Term Investments | 1,031 | 1,025 | 1,249 | 984.45 | 927.15 | 695.95 | Upgrade
|
| Goodwill | - | - | - | 97.64 | 97.64 | 97.64 | Upgrade
|
| Other Intangible Assets | 830.87 | 833.37 | 842.67 | 854.64 | 812.75 | 815.17 | Upgrade
|
| Long-Term Deferred Tax Assets | 16.84 | 21.36 | 27.47 | 32.27 | 1.09 | 8.96 | Upgrade
|
| Long-Term Deferred Charges | 319.26 | 308 | 234.36 | 150.71 | 120.45 | 82.41 | Upgrade
|
| Other Long-Term Assets | 158.38 | 107.34 | 53.31 | 16.6 | 8.87 | 316.3 | Upgrade
|
| Total Assets | 4,077 | 4,095 | 3,920 | 3,781 | 3,425 | 3,371 | Upgrade
|
| Accounts Payable | 38.77 | 31.2 | 73.57 | 82.97 | 48.47 | 46.74 | Upgrade
|
| Accrued Expenses | 23.56 | 50.01 | 45.68 | 32.15 | 26.82 | 33.99 | Upgrade
|
| Short-Term Debt | 266.16 | 253.45 | 140.96 | 96.93 | - | - | Upgrade
|
| Current Portion of Long-Term Debt | 9.29 | 9.25 | 1.07 | 5.12 | - | - | Upgrade
|
| Current Portion of Leases | - | - | 7 | 3.95 | 8.71 | 7.5 | Upgrade
|
| Current Income Taxes Payable | 7.74 | 11.69 | 4.69 | 0.25 | 34.12 | 15.84 | Upgrade
|
| Current Unearned Revenue | 3.92 | 5.95 | 6.43 | 6.49 | 2.92 | 1.2 | Upgrade
|
| Other Current Liabilities | 84.37 | 97.89 | 73.29 | 95.53 | 51.32 | 49.49 | Upgrade
|
| Total Current Liabilities | 433.81 | 459.45 | 352.68 | 323.39 | 172.36 | 154.77 | Upgrade
|
| Long-Term Debt | 54.01 | 54.28 | 49.85 | 43.78 | - | - | Upgrade
|
| Long-Term Leases | 1.46 | 3.17 | 10.8 | - | 3.71 | 11.12 | Upgrade
|
| Long-Term Unearned Revenue | 40.59 | 41.87 | 40.48 | 23.49 | 28.98 | 29.83 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 39.54 | 39.74 | 39.72 | 27.78 | 29.62 | 45.02 | Upgrade
|
| Total Liabilities | 569.41 | 598.51 | 493.52 | 418.44 | 234.68 | 240.74 | Upgrade
|
| Common Stock | 159.01 | 159.01 | 159.36 | 160 | 160 | 160 | Upgrade
|
| Additional Paid-In Capital | 949.82 | 948.77 | 944.6 | 955.01 | 992.46 | 985.17 | Upgrade
|
| Retained Earnings | 2,162 | 2,115 | 2,045 | 2,050 | 1,931 | 1,876 | Upgrade
|
| Treasury Stock | -75.93 | -32.86 | -35.93 | -78.59 | -124.64 | -124.64 | Upgrade
|
| Comprehensive Income & Other | 25.93 | 21.14 | 31.8 | -26.5 | -32.8 | -8.11 | Upgrade
|
| Total Common Equity | 3,221 | 3,211 | 3,144 | 3,060 | 2,926 | 2,889 | Upgrade
|
| Minority Interest | 286.51 | 285.21 | 281.75 | 302.44 | 264.22 | 241.81 | Upgrade
|
| Shareholders' Equity | 3,508 | 3,496 | 3,426 | 3,362 | 3,190 | 3,131 | Upgrade
|
| Total Liabilities & Equity | 4,077 | 4,095 | 3,920 | 3,781 | 3,425 | 3,371 | Upgrade
|
| Total Debt | 330.92 | 320.16 | 209.67 | 149.78 | 12.42 | 18.62 | Upgrade
|
| Net Cash (Debt) | 456.56 | 512.84 | 484.79 | 660.65 | 613.94 | 600.31 | Upgrade
|
| Net Cash Growth | 21.25% | 5.79% | -26.62% | 7.61% | 2.27% | -60.08% | Upgrade
|
| Net Cash Per Share | 2.87 | 3.21 | 3.10 | 4.22 | 3.93 | 3.81 | Upgrade
|
| Filing Date Shares Outstanding | 157.38 | 158.63 | 159.22 | 158.98 | 156.49 | 156.49 | Upgrade
|
| Total Common Shares Outstanding | 157.38 | 158.63 | 158.83 | 158.98 | 156.49 | 156.49 | Upgrade
|
| Working Capital | 888.84 | 936.08 | 733.86 | 906.57 | 844.35 | 793.06 | Upgrade
|
| Book Value Per Share | 20.47 | 20.24 | 19.80 | 19.25 | 18.70 | 18.46 | Upgrade
|
| Tangible Book Value | 2,390 | 2,378 | 2,302 | 2,108 | 2,016 | 1,976 | Upgrade
|
| Tangible Book Value Per Share | 15.19 | 14.99 | 14.49 | 13.26 | 12.88 | 12.63 | Upgrade
|
| Buildings | - | - | 324.61 | 322.64 | 323.38 | 322.3 | Upgrade
|
| Machinery | - | - | 126.83 | 125.74 | 126.76 | 114.72 | Upgrade
|
| Construction In Progress | - | - | 209.85 | 190.8 | 181.98 | 127.26 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.